Standard
Pregnancy outcomes in women with type 1 diabetes using insulin degludec : response to Kamran et al. / Ringholm, Lene; Do, Nicoline Callesen; Damm, Peter; Mathiesen, Elisabeth Reinhardt.
I:
Acta Diabetologica, Bind 60, Nr. 1, 2023, s. 141-142.
Publikation: Bidrag til tidsskrift › Kommentar/debat › Forskning › fagfællebedømt
Harvard
Ringholm, L, Do, NC
, Damm, P & Mathiesen, ER 2023, '
Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al',
Acta Diabetologica, bind 60, nr. 1, s. 141-142.
https://doi.org/10.1007/s00592-022-01996-8APA
Ringholm, L., Do, N. C.
, Damm, P., & Mathiesen, E. R. (2023).
Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al.
Acta Diabetologica,
60(1), 141-142.
https://doi.org/10.1007/s00592-022-01996-8Vancouver
Ringholm L, Do NC
, Damm P, Mathiesen ER.
Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al.
Acta Diabetologica. 2023;60(1):141-142.
https://doi.org/10.1007/s00592-022-01996-8Author
Ringholm, Lene ; Do, Nicoline Callesen ; Damm, Peter ; Mathiesen, Elisabeth Reinhardt. / Pregnancy outcomes in women with type 1 diabetes using insulin degludec : response to Kamran et al. I: Acta Diabetologica. 2023 ; Bind 60, Nr. 1. s. 141-142.
Bibtex
@article{774e8d5e3107473aa0329586aa52fe2e,
title = "Pregnancy outcomes in women with type 1 diabetes using insulin degludec: response to Kamran et al",
author = "Lene Ringholm and Do, {Nicoline Callesen} and Peter Damm and Mathiesen, {Elisabeth Reinhardt}",
note = "Funding Information: ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation. Funding Information: L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator-sponsored study. ",
year = "2023",
doi = "10.1007/s00592-022-01996-8",
language = "English",
volume = "60",
pages = "141--142",
journal = "Acta Diabetologica",
issn = "0940-5429",
publisher = "Springer",
number = "1",
}
RIS
TY - JOUR
T1 - Pregnancy outcomes in women with type 1 diabetes using insulin degludec
T2 - response to Kamran et al
AU - Ringholm, Lene
AU - Do, Nicoline Callesen
AU - Damm, Peter
AU - Mathiesen, Elisabeth Reinhardt
N1 - Funding Information:
ERM has received fees for giving talks for Novo Nordisk A/S. ERM, PD and LR are participating in multicenter and multinational clinical studies on the use of insulin in pregnant women with pre-existing diabetes in collaboration with Novo Nordisk; no personal honorarium is involved. NCD is funded by Novo Nordisk Foundation.
Funding Information:
L. Ringholm has received a research grant from Novo Nordisk (Grant number: U1111-1209-6358) for an investigator-sponsored study.
PY - 2023
Y1 - 2023
U2 - 10.1007/s00592-022-01996-8
DO - 10.1007/s00592-022-01996-8
M3 - Comment/debate
C2 - 36283987
AN - SCOPUS:85141061788
VL - 60
SP - 141
EP - 142
JO - Acta Diabetologica
JF - Acta Diabetologica
SN - 0940-5429
IS - 1
ER -
